Journal of the Korean Ophthalmological Society 2005;46(2):323-329.
Published online February 28, 2005.
Molecular Diagnosis for Mitochondrial DNA Aberrations in Chronic Progressive External Ophthalmoplegia.
Moon Woo Seong, Jeong Min Hwang, Ji Yeon Kim, Hyun Soo Ko, Sung Sup Park
1Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul National University, Seoul, Korea.
2Seoul National University Hospital Clinical Research Institute, Seoul, Korea.
3Department of Ophthalmology, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, Korea. hjm@snu.ac.kr
4Seoul Seobu Blood Center, Korean Red Cross, Seoul, Korea.
만성진행외안근마비의 사립체 유전체의 이상과 분자진단법에 대한 연구
성문우1,황정민2,김지연3,고현수1,박성섭1
Department of Laboratory Medicine, Seoul National University College of Medicine & Seoul National University Hospital Clinical Research Institute1, Seoul, Korea Department of Ophthalmology, Seoul National University College of Medicine and Seoul National University Bundang Hospital2, Seongnam, Korea, Seoul Seobu Blood Center, Korean Red Cross3, Seoul, Korea
Correspondence:  Moon-Woo Seong, M.D.1
Abstract
PURPOSE
To evaluate the spectrum of mitochondrial DNA (mtDNA) aberrations in patients with suspected chronic progressive external ophthalmoplegia (CPEO) and to establish the molecular diagnostic method for CPEO in Koreans. METHODS: We performed mtDNA analyses for single deletions with long-range PCR and direct sequencing, and for the nine important point mutations including 3243A>G and 8344A>G with PCR/RFLP in muscles, bloods and paraffin-embedded muscle sections of 16 Korean patients with suspected CPEO. RESULTS: Three novel single mtDNA deletions were identified in three patients' muscles: 3159bp deletion from np 6657 to np 9815, 7591bp from np 8429 to np 16019, and 6191bp from np 7799 to np 13989. In addition, multiple mtDNA deletions were found in one patient. None of the blood specimen had mtDNA deletions even in the patients with mtDNA deletion in muscle. All single deletion junctions were flanked by direct repeats of 6-8 bp. None of the nine mtDNA point mutations were found in muscles, bloods or paraffin-embedded muscle sections. CONCLUSIONS: We identified three novel single deletions by mtDNA analyses in the muscles of 3 patients with CPEO. However, point mutations were not found. Furthermore, we established a molecular diagnostic method for CPEO in Korea. Long-range PCR and direct sequencing of the muscles were appropriate as a molecular diagnostic method for CPEO in Koreans.
Key Words: Chronic progressive external ophthalmoplegia;Deletion;Mitochondrial DNA;Molecular diagnosis;Mutation


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next